Diagnostic equipment provider Avacta Group is expanding its animal health operations through the acquisition of Reactivlab.
Avacta is paying an initial £80,000 in shares - at roughly 1.8p a share - with two more potential deferred payments based on percentages of sales volumes in the second (30%) and third years (100%) after completion of the purchase. These payments will be in shares at a minimum price of 1.5p each. The maximum deferred consideration is £5m.
Reactivlab develops veterinary diagnostic tests using Acute-Phase Proteins. These are a class of proteins whose concentrations in the blood change as part of the immune and inflammatory response to a wide range of problems such as infections, diabetes, hypertension and cardiovascular disease.
Reactivlab generated revenues of £142,000 and a similar loss in the year to July 2009. There was cash in the bank of £83,000 at the end of 2009.
The deal will provide additional tests that could be used with Avacta’s equipment and supplied through its laboratory services business.
At 1.77p a share, up 0.025p on the day, Avacta is valued at £22.8m.
© 2007 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Mobile messaging technology provider Synchronica, which is the subject of a contested, all-share bid from rival Myriad AG, has signed a letter of intent with TSX Venture Exchange-quoted Intertainment Media.
AIM-quoted Timeweave has bought convertible loan notes in DCD Media that can convert into a 29.9% stake in the TV programmes producer.
Paper and speciality fibres manufacturer James Cropper is investing $3m in a new manufacturing facility in New York State.
Peter Gyllenhammar has taken his stake in TEG Group to 3.2% following the purchase of 500,000 shares.
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds